An S2 Fluorescence Model for Interpreting High-Resolution Cometary Spectra. I. Model Description and Initial Results

A new versatile model providing S2 fluorescence spectrum as a function of time is developed with the aim of interpreting high resolution cometary spectra. For the S2 molecule, it is important to take into account both chemical and dynamic processes because S2 has a short lifetime and is confined in the inner coma where these processes are most important. The combination of the fluorescence model with a global coma model allows for the comparison with observations of column densities taken through an aperture and for the analysis of S2 fluorescence in different parts of the coma. Moreover, the model includes the rotational structure of the molecule. Such a model is needed for interpreting recent high spectral resolution observations of cometary S2. A systematic study of the vibrational-rotational spectrum of S2 is undertaken, including relevant effects, such as non-equilibrium state superposition and the number density profile within the coma due to dynamics and chemistry, to investigate the importance of the above effects on the scale length and abundance of S2 in comets.Comment: 20 pages, 7 figure

Occupational Exposure to Hydrazine and Subsequent Risk of Lung Cancer: 50-Year Follow-Up

Hydrazine is carcinogenic in animals, but there is inadequate evidence to determine if it is carcinogenic in humans. This study aimed to evaluate the association between hydrazine exposure and the risk of lung cancer.The cause specific mortality rates of a cohort of 427 men who were employed at an English factory that produced hydrazine between 1945 and 1971 were compared with national mortality rates.By the end of December 2012 205 deaths had occurred. For men in the highest exposure category with greater than two years exposure and after more than ten years since first exposure the relative risks compared with national rates were: 0.85 (95% CI: 0.18-2.48) for lung cancer, 0.61 (95% CI: 0.07-2.21) for cancers of the digestive system, and 0.44 (95% CI: 0.05-1.57) for other cancers.After 50 years of follow up, the results provide no evidence of an increased risk of death from lung cancer or death from any other cause